Rafael Pharmaceuticals, Ono Pharmaceutical to accelerate clinical development of cancer drug candidate CPI-613

Image: Rafael Pharmaceuticals and Ono Pharmaceutical have collaborated to accelerate clinical development of cancer drug candidate CPI-613. Photo: courtesy of Phoenix Locklear from Pixabay.